The management of psychiatric problems during pregnancy and lactation represents a unique and complex clinical situation. When women take psychotropic medications in these conditions, they and their fetus or neonate may experience unwanted, adverse effects due to these medications. In the 1st trimester, teratogenicity is the main drug risk, in the 2-3rd trimester, growth retardation and neurological damage may occur and after birth, drug withdrawal effects may occur. Women may also experience sexual dysfunction or amenorrhea.
Therefore, under the these background we reviewed adverse effects, malformations during pregnancy and lactation, and female endocrine dysfunctions. We also reviewed the principles and management of those situations.
|